AMCP Spring 2013
According to the The Academy of Managed Care Pharmacy, the meeting is the "nation's largest gathering of managed care pharmacists." There will be 40 educational programs and it is a "not-to-be missed event."
Coming Soon
NOW AVAILABLE: AMCP Spring 2013 Conference Coverage
Highlights from The Academy of Managed Care Pharmacy's 25th Meeting & Expo, which took place on April 25, 2013, in San Diego, CA, are available in a newsletter published by The American Journal of Managed Care.
Day 1
Debora Sternaman, PharmD, Discusses the Health Insurance Marketplace
Debora Sternaman, PharmD, the director of commercial formulary services at Catamaran in Georgetown, TX discusses the Health Insurance Marketplace and how the new model offers a different experience from the current managed care structure.
Collaborative Care Strategies in Hemophilia Management: Driving Patient Outcomes in a Changing Managed Care Environment
In a presentation entitled "Hemophilia Management: Collaborating in a New Era to Optimize Cost and Clinical Outcomes in Managed Care," 5 key thought leaders and managed care authorities shared their insights on the changing therapeutic landscape for hemophilia management.
Robert W. Dubois, MD, PhD, Describes the Initial Expectations of Accountable Care Organizations
Robert W. Dubois, MD, PhD, the chief science officer of the National Pharmaceutical Council discusses the initial expectations of implementing accountable care organizations (ACOs) and how those expectations have evolved over time.
The Advent of Accountable Care Organizations: A Shift in the Managed Care Paradigm
In a presentation entitled "Accountable Care Organizations: 2013 and Beyond," 4 managed care experts shared their insights and thoughts on the ongoing paradigm shift in managed care towards accountable care organizations, elaborating on current trends, unmet needs, and the future direction of the managed care landscape.
Day 2
Optimizing Care Delivery with Medicare Star Ratings: The Successes and Challenges of Managed Care Organizations
In an educational seminar entitled "How Much of the $3 Billion in Star Rating Bonuses Did Your MCO Capture?," David Nau, RPh, PhD, CPHQ, FAPhA, along with his colleagues, discussed Medicare star ratings and how managed care organizations have implemented practices and processes to ensure the delivery of high-quality care to their members.
Rebecca P. Snead, RPh, Discusses the Current Movement Toward Pharmacist Provider Status
Rebecca P. Snead, RPh, the executive vice president and CEO of the National Alliance of State Pharmacy Associations, discusses the current movement toward pharmacist provider status, and elaborates on the challenges and opportunities encountered.
Balancing Biologics With Managed Care Considerations: Advancing Therapeutic Strategies for Chronic Diseases
In an educational session satellite symposium entitled "Biologic Therapies for Chronic Diseases: Factors Influencing Treatment Decisions," Robert P. Navarro, PharmD, along with his colleagues, delves into the current trends of specialty pharmacy and biological therapies, and how managed care discussions have evolved to optimize patient outcomes within a cost-constrained healthcare environment.
Eric Wright, PharmD, BCPS, Addresses How MMOTs Influence Current Managed Care
Eric A. Wright, PharmD, BCPS, an investigator at the Geisinger Center for Health Research, discusses the implications of medical moments of truth (MMOTs) on current therapeutic and managed care strategies.
Day 3
Daniel Tomaszewski, PharmD, Discusses How Practices in Managed Care Pharmacy Guided Legislation
Daniel Tomaszewski, PharmD, PhD Candidate, an assistant professor at the University of Minnesota, College of Pharmacy, Duluth, discusses the impact of managed care pharmacy on current legislation, regulatory policies, and ongoing healthcare reform.
The Evolution of Therapeutic Strategies for Multiple Sclerosis: Balancing Clinical Outcomes With Managed Care
In an educational symposium entitled, "The Evolution of Multiple Sclerosis Treatment: The Role of the Managed Care Pharmacist," Kristen Helms, PharmD, and her 2 colleagues discuss how treatments for multiple sclerosis (MS) have evolved over the past 2 decades, explore the novel and emerging therapeutic strategies for MS, and cover strategies to improve medication adherence for the chronic disease.
Yelena Yankovskaya, PharmD, Discusses the Expectations and Roles of VBID in Combating Nonadherence
Yelena Yankovskaya, PharmD, a managed markets fellow at the Mayes College of Healthcare Business and Policy, describes the expectations and roles of predictive modeling, value-based insurance design, and gamification/social media in contemporary managed care pharmacy.
Optimizing Managed Care Strategies Amidst a Growing Orphan Drug Pipeline
Mattias Cheung, PhD, FCSHP, FASHP, discusses the ongoing progress of orphan drugs for rare diseases in today's health care environment, and explores their challenges and opportunities in the current managed care landscape.
Matthias Cheung, PhD, Discusses Current Federal Legislation and Ongoing Policies Regarding Orphan Drugs and Rare Disease
Matthias Cheung, PhD, FCSHP, FASHP, a principal at Advanced Rx Consulting, LLC, and an adjunct professor of pharmacy practice at the University of the Pacific, Thomas J. Long School of Pharmacy and Health Services, discusses the circumstances and factors that catalyzed the passage of current legislation and regulatory policies for orphan drugs, rare diseases, and ultra-rare diseases.